ADAGE CAPITAL PARTNERS GP LLC 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 09:15 am Sale |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
ADAGE CAPITAL PARTNERS GP LLC | 650,000 1.390% |
-1,850,000 (-74.00%) |
Filing |
| 2021-02-11 07:39 am Purchase |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
ADAGE CAPITAL PARTNERS GP LLC | 2,500,000 6.320% |
600,000 (+31.58%) |
Filing |
| 2020-07-24 4:05 pm Purchase |
2020-07-14 | 13G | Celldex Therapeutics, Inc. CLDX |
ADAGE CAPITAL PARTNERS GP LLC | 1,900,000 5.010% |
1,900,000 (New Position) |
Filing |